FLEXDOSE® - 2D/3D printing technology

  • FLEXDOSE® - 2D/3D printing technology 1
  • FLEXDOSE® - 2D/3D printing technology 2
Product Description

FLEXDOSE® is the only pharmaceutical printer in the world that uses 2D printing in formulation manufacturing. In addition, FLEXDOSE® offers 3D printing options in the same housing. FLEXDOSE® is patented, CE certified, GMP compliant and has containment options to handle HPAPIs. We are already successfully working on projects globally to use FLEXDOSE® Printing. The hardware and software, largely designed by DiHeSys itself, has been developed, manufactured and perfectly coordinated by our experts. Thus, FLEXDOSE® enables precise, highly specialized and time-efficient printing of up to four APIs in one printing process.

Read more Show less

DiHeSys GmbH

  • DE
  • 2019
    On CPHI since
  • 1
    Certificates
  • 25 - 49
    Employees
Company types
Manufacturer/Innovator
Other
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    DiHeSys develops 2D and 3D printer for the use in the pharmaceutical environment. These printers allow a cost-effective production of inividual dosage forms in a small batch size. Contact us for more information.
  • Selling Points
    Cardiovascular Health; Children's Health F&B; Convenience; Experienced Technicians; Place of Origin; Product Features; Product Performance; Sustainability
  • Model
    FLEXDOSE Printer
  • Supplied from
    Germany
More specifications Fewer specifications
Sales Markets
Show more Show less

DiHeSys GmbH

  • DE
  • 2019
    On CPHI since
  • 1
    Certificates
  • 25 - 49
    Employees
Company types
Manufacturer/Innovator
Other
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile

More Products from DiHeSys GmbH (1)

  • Formulation development for generics

    Product Formulation development for generics

    At DiHeSys, we develop inks and polymers - individually for every single active ingredient. The corresponding formulation development takes place primarily in cooperation with the pharmaceutical industry. This approach allows us to offer our customers a steadily growing range of formulations tailored to th...